← Back to Search

Behavioural Intervention

Exercise for Prostate Cancer (EMMPC Trial)

N/A

Waitlist Available

Led By Peter Black, MD

Research Sponsored by Vancouver Prostate Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age over 19

Be older than 18 years old

Must not have

Men with a medical, musculoskeletal condition or use of mobility aid that prevents participation in the exercise intervention.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether an exercise program can improve outcomes for men with prostate cancer.

Who is the study for?

This trial is for men over 19 with prostate cancer who are fit for radical prostatectomy, do less than 90 minutes of moderate exercise weekly, have a BMI under 40, and can speak English. They must commit to the study schedule including twice-weekly visits for exercise and be able to give informed consent.

What is being tested?

The study tests if an exercise program before surgery can affect disease progression in prostate cancer patients. Participants will either join a 4-12 week exercise regimen or receive standard care only, with assessments throughout the intervention and up to six months after surgery.

What are the potential side effects?

Since this trial involves an exercise program rather than medication, side effects may include typical physical responses to increased activity such as muscle soreness or fatigue but should generally be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am older than 19 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot join the exercise program due to a health or mobility issue.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Biological: Collection of urine, blood, biopsy and RP specimens

Physical Fitness: Aerobic fitness using a submaximal graded exercise test

Physical Fitness: Anthropometrics (i.e. BMI & waist circumference)

+8 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ARM1: Exercise InterventionExperimental Treatment1 Intervention

The exercise program is a 4-12 weeks progressive combined resistance and aerobic exercise for participants from time of diagnosis to RP. Participants will undergo twice weekly group-training (four-six participants/group) combined aerobic-resistance sessions (1hr per session), supervised by trained exercise therapists. In addition, participants will undergo home-based aerobic exercise independently three times a week with the goal to meet the current physical activity guidelines for cancer survivors (150min/week of moderate intensity aerobic activity and two resistance training sessions per week). Participants will also be supplied with the Canadian Physical Activity and Sedentary Behavior Guidelines Handbook and accompanying Log Sheets.

Group II: ARM2: Control GroupActive Control1 Intervention

Participants will be asked to exercise as they normally would and will be asked to record their exercise activity on provided activity logs.

0 / 2Eligibility criteria met